期刊信息查詢系統

期刊標題檢索 TRANSL LUNG CAN 最新評論: Why is no one sharing their experience in this magazine? I submitted a... (2024-09-19)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Translational Lung Cancer Research]您好，您是該頁面的第 29415 位訪客。

期刊簡介

期刊名稱

Translational Lung Cancer Research
LetPub Score

7.0

50 ratings

Rate

Reputation

8.2

Influence

6.0

Speed

7.0

期刊簡稱

TRANSL LUNG CANCER R

ISSN

2218-6751

h-index

N.A.

CiteScore

SJR

SNIP

CiteScore Rank

7.20

1.318

0.948

Subject field	Quartiles	Rank	Percentile
Category: Medicine Subcategory: Oncology	Q1	92 / 404

自引率 (2023-2024)

5.00%自引率趨勢

掲載範囲

Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.

官方網站

http://tlcr.amegroups.com/

在線稿件提交

http://tlcr.amegroups.com/login?source=%2Fauthor%2Fsubmit

開放訪問

Yes

出版商

Society for Translational Medicine (STM)

主題領域

Medicine

出版國/地區

Hong Kong

發行頻率

月刊

創刊年

2012

每年文章數

172每年文章數趨勢

黃金OA百分比

98.74%

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q1

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
ONCOLOGY	SCIE	Q2	95/322
RESPIRATORY SYSTEM	SCIE	Q1	22/100

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-6751%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: In-house review: 1-3 weeks
External peer review: 1-3 months
Publication Ahead of Print: within 1 month after being accepted

競爭力 *

來自作者的數據:

參考鏈接

相關期刊	【Translational Lung Cancer Research】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
Nature Cancer	H-index: 0 CiteScore: 31.10
JAMA Oncology	H-index: 41 CiteScore: 37.50
JAMA Oncology	H-index: 61 CiteScore: 37.50
Trends in Cancer	H-index: 0 CiteScore: 28.50
Liver Cancer	H-index: 25 CiteScore: 20.80
Experimental Hematology & Oncology	H-index: 0 CiteScore: 12.60
ESMO Open	H-index: 0 CiteScore: 11.70
Cancer Biology & Medicine	H-index: 29 CiteScore: 9.80
Annual Review of Cancer Biology	H-index: 0 CiteScore: 14.50
Cancers	H-index: 53 CiteScore: 8.00

學科內最受檢索的期刊	頁面查看次數
Cancers	209499
OncoTargets and Therapy	183269
Cancer Management and Research	149109
Journal of Oncology	88244
Cancer Biology & Medicine	58478
Molecular Therapy-Oncolytics	43575
JAMA Oncology	36960
Liver Cancer	34134
Nature Cancer	33324
JAMA Oncology	28793

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Translational Lung Cancer Research] 的評論	撰寫評論

作者: xxkk

領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受

撰寫評論

2024-09-19 15:20:58 評論於

Why is no one sharing their experience in this magazine? I submitted an article this year, let me tell you about it. It's a clinical article on thoracic surgery. It took 2 months for the initial review, then major revisions were needed. After resubmitting, it took another month for minor revisions and acceptance. It will be published in about a month, so the whole process took almost 4 to 5 months. The requirements are quite strict, and the reviewers are very thorough. Their feedback greatly improved the article, so there is a good opportunity for substantial revisions.

(0) 讚！ | xxkk

開始撰寫 [Translational Lung Cancer Research] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

Translational Lung Cancer Research

期刊標題檢索 TRANSL LUNG CAN 最新評論: Why is no one sharing their experience in this magazine? I submitted a... (2024-09-19)

[Translational Lung Cancer Research]您好，您是該頁面的第 29415 位訪客。

開始撰寫 [Translational Lung Cancer Research] 的評論：

Contact us